Macrophage migration inhibitory factor (MIF), a novel factor regulates hyperphagia and obesity associated with atypical antipsychotics

巨噬细胞迁移抑制因子（MIF），一种调节与非典型抗精神病药物相关的食欲过盛和肥胖的新因子

• 批准号: 370493
• 负责人: Qi Dake
• 金额: $ 47.37万
• 依托单位: Memorial University of Newfoundland
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=370493&lang=en
• 关键词: Atyical Antipsychotics; Macrophage Migration Inhibitory Factor; Metabolic Dysfunction; Procytokine

Severe mental disorders such as schizophrenia or bipolar disorder affect more than 2% of the Canadian population, especially youth. Atypical antipsychotics (AAPs) are the first-line medications for treating these diseases, while they are often associated

精神分裂症或躁郁症等严重的精神障碍会影响加拿大人口的2％以上，尤其是青年。非典型抗精神病药（AAP）是治疗这些疾病的一线药物，而它们通常是相关的